News & Press Releases

Mintz advised Synlogic, Inc. in its definitive merger agreement with Caldera Therapeutics, Inc. in an all-stock transaction pursuant to which both companies will become wholly owned subsidiaries of a newly formed company that will operate as Caldera Therapeutics, Inc. The transaction is supported by an upsized $278 million concurrent private placement financing from a syndicate of new and existing investors and is expected to close concurrently with the completion of the merger.

Theresa Carnegie was quoted in a Corporate Counsel article discussing the FTC's settlement with CVS Caremark, the agency's evolving approach to pharmacy benefit manager regulation, and what it could mean for the industry's future.

Michelle Capezza was quoted in a Fiduciary News article discussing the role of automatic enrollment and escalation features in retirement plans and the impact of the SECURE 2.0 Act on plan design.

Mintz advised the placement agents in connection with the $39 Million private placement that is expected to close in connection with the completion of the merger transaction between Scancell Holdings plc and Neuphoria Therapeutics Inc. The private placement is part of up to $89 million of financing expected to be raised by Scancell in connection with the merger transaction through a combination of equity and debt.

Nicholas Gravante Jr. was profiled in Lawdragon's Lawyer Limelight series, reflecting on his four-decade litigation career, the mentors who influenced his development as a trial lawyer, and his decision to join Mintz earlier this year with a team of longtime colleagues.

Michelle Capezza’s insights were featured in a Fiduciary News article examining why email open rates may not accurately reflect participant engagement with retirement plans and how plan sponsors should look beyond these metrics to assess whether participant communications are supporting informed decision-making and retirement readiness in fulfillment of their ERISA fiduciary responsibilities.